Principal Financial Group Inc Design Therapeutics, Inc. Transaction History

Principal Financial Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$2.27 - $4.03 $6,172 - $10,957	-2,719 Reduced 17.87%	12,497 $50,000
Q4 2023 Feb 07, 2024	SELL	$1.99 - $2.76 $1.4 Million - $1.94 Million	-701,602 Reduced 97.88%	15,216 $40,000
Q3 2023 Nov 02, 2023	SELL	$2.05 - $8.14 $23,376 - $92,820	-11,403 Reduced 1.57%	716,818 $1.69 Million
Q2 2023 Aug 07, 2023	BUY	$4.99 - $7.64 $41,337 - $63,289	8,284 Added 1.15%	728,221 $4.59 Million
Q1 2023 May 09, 2023	SELL	$5.5 - $9.77 $345,246 - $613,282	-62,772 Reduced 8.02%	719,937 $4.15 Million
Q4 2022 Feb 09, 2023	SELL	$7.86 - $17.2 $292,997 - $641,164	-37,277 Reduced 4.55%	782,709 $8.03 Million
Q3 2022 Nov 09, 2022	BUY	$14.09 - $25.57 $934,068 - $1.7 Million	66,293 Added 8.8%	819,986 $13.7 Million
Q2 2022 Aug 10, 2022	BUY	$9.91 - $17.33 $2.08 Million - $3.64 Million	209,781 Added 38.57%	753,693 $10.6 Million
Q1 2022 May 09, 2022	BUY	$11.17 - $20.89 $239,685 - $448,257	21,458 Added 4.11%	543,912 $8.78 Million
Q4 2021 Feb 09, 2022	BUY	$13.64 - $21.41 $4.12 Million - $6.46 Million	301,944 Added 136.93%	522,454 $11.2 Million
Q3 2021 Nov 09, 2021	BUY	$13.99 - $20.03 $126,021 - $180,430	9,008 Added 4.26%	220,510 $3.24 Million
Q2 2021 Aug 10, 2021	BUY	$19.02 - $29.78 $1.98 Million - $3.1 Million	104,094 Added 96.91%	211,502 $4.21 Million
Q1 2021 May 24, 2021	BUY	$29.52 - $41.49 $3.17 Million - $4.46 Million	107,408 New	107,408 $3.21 Million

32.1M

4.6K

2.6K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $272M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.